The University of MD Anderson Cancer Center and Rice University, both based in Houston, have launched a Cancer Bioengineering Collaborative, a hub that aims to advance cancer research and accelerate the time it takes to turn findings into clinical use.
Uncategorized
Philadelphia-based Jefferson Health will consolidate all of its cardiac and vascular services under a new institute, established through a "transformational" gift.
Hackathons — events wherein programmers come together for days at a time to solve a problem — are a staple in the technology community. Durham, N.C.-based Duke Health is using a similar model to get high school students excited about…
Hersey, Pa.-based Penn State Health broke ground on its new cancer center.
In an age of advanced technology and personalized medicine, curing prostate cancer is not always necessary, the Association of American Medical Colleges said in a June 25 article.
Wu Liu, PhD, a medical physicist who created new imaging techniques and radiation treatments for cancer, died May 14 of brain cancer at 51.
Leaders at the American Society of Clinical Oncology published a formal document June 25 that outlines what the group deems as the most appropriate use of artificial intelligence when it comes to clinical oncology care.
There are predicted to be approximately 1.96 million new cancer cases in 2023, with a projected 609,000 deaths, USA Facts reported.
Despite 2019 recommendations from the American College of Cardiology and the American Heart Association warning adults against routinely taking aspirin for heart health, many are still doing so, according to a new study from Cleveland Clinic researchers.
Vutrisiran, a new drug made by Alnylam Pharmaceuticals to treat ATTR amyloidosis with cardiomyopathy, reduced the risk of death by 36% in patients, the drugmaker announced June 24.